| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 368.742 | 89 |
| GSM780708 | Untreated after 4 days (C2_1) | 392.368 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 391.164 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 363.047 | 89 |
| GSM780720 | Untreated after 4 days (C2_2) | 338.76 | 88 |
| GSM780721 | Untreated after 4 days (C3_2) | 366.155 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 337.067 | 88 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 365.449 | 89 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 330.051 | 88 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 340.798 | 88 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 339.424 | 88 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 309.574 | 88 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 388.35 | 90 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 372.989 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 349.617 | 89 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 378.431 | 89 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 420.74 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 379.772 | 89 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 211.875 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 247.675 | 86 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 323.261 | 88 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 192.476 | 83 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 262.211 | 86 |